Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Malignant Lymphoma

  Free Subscription


23.12.2018

1 Biochem Biophys Res Commun
2 Blood
1 Bone Marrow Transplant
1 Br J Dermatol
1 Br J Haematol
2 Cancer
1 Int J Radiat Oncol Biol Phys
1 J Clin Oncol
1 Leuk Lymphoma


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Biochem Biophys Res Commun

  1. ZHU XW, Wang J, Zhu MX, Wang YF, et al
    MicroRNA-506 inhibits the proliferation and invasion of mantle cell lymphoma cells by targeting B7H3.
    Biochem Biophys Res Commun. 2018 Dec 12. pii: S0006-291X(18)32698.
    PubMed     Text format     Abstract available


    Blood

  2. GROMMES C, Tang SS, Wolfe J, Kaley TJ, et al
    Phase Ib trial of an ibrutinib-based combination therapy in recurrent/refractory CNS lymphoma.
    Blood. 2018 Dec 19. pii: blood-2018-09-875732. doi: 10.1182/blood-2018-09-875732
    PubMed     Text format     Abstract available

  3. WAGENER R, Seufert J, Raimondi F, Bens S, et al
    The mutational landscape of Burkitt-like lymphoma with 11q aberration is distinct from that of Burkitt lymphoma.
    Blood. 2018 Dec 19. pii: blood-2018-07-864025. doi: 10.1182/blood-2018-07-864025
    PubMed     Text format     Abstract available


    Bone Marrow Transplant

  4. JIN A, Feng J, Wang Z, Jiang L, et al
    Severe dyspnea caused by rapid enlargement of cervical lymph node in a relapsed/refractory B-cell lymphoma patient following chimeric antigen receptor T-cell therapy.
    Bone Marrow Transplant. 2018 Dec 18. pii: 10.1038/s41409-018-0412.
    PubMed     Text format     Abstract available


    Br J Dermatol

  5. GILSON D, Whittaker SJ, Child FJ, Scarisbrick JJ, et al
    British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous lymphomas 2018.
    Br J Dermatol. 2018 Dec 17. doi: 10.1111/bjd.17240.
    PubMed     Text format    


    Br J Haematol

  6. RULE S, Cook G, Russell NH, Hunter A, et al
    Allogeneic stem cell transplantation as part of front line therapy for Mantle cell lymphoma.
    Br J Haematol. 2018 Dec 17. doi: 10.1111/bjh.15723.
    PubMed     Text format     Abstract available


    Cancer

  7. RIGTER LS, Spaander MCW, Aleman BMP, Bisseling TM, et al
    High prevalence of advanced colorectal neoplasia and serrated polyposis syndrome in Hodgkin lymphoma survivors.
    Cancer. 2018 Dec 18. doi: 10.1002/cncr.31903.
    PubMed     Text format     Abstract available

  8. HOLMQVIST AS, Chen Y, Berano Teh J, Sun C, et al
    Risk of solid subsequent malignant neoplasms after childhood Hodgkin lymphoma-identification of high-risk populations to guide surveillance: A report from the Late Effects Study Group.
    Cancer. 2018 Dec 17. doi: 10.1002/cncr.31807.
    PubMed     Text format     Abstract available


    Int J Radiat Oncol Biol Phys

  9. WIRTH A, Prince HM, Roos D, Gibson J, et al
    A prospective, multicentre study of involved-field radiotherapy with autologous stem cell transplantation for patients with Hodgkin lymphoma and aggressive non-Hodgkin lymphoma (ALLG HDNHL04/TROG 03.03).
    Int J Radiat Oncol Biol Phys. 2018 Dec 13. pii: S0360-3016(18)34123.
    PubMed     Text format     Abstract available


    J Clin Oncol

  10. JACOBSON CA
    CD19 Chimeric Antigen Receptor Therapy for Refractory Aggressive B-Cell Lymphoma.
    J Clin Oncol. 2018 Dec 13:JCO1801457. doi: 10.1200/JCO.18.01457.
    PubMed     Text format     Abstract available


    Leuk Lymphoma

  11. GULATI N, Beguelin W, Giulino-Roth L
    Enhancer of zeste homolog 2 (EZH2) inhibitors.
    Leuk Lymphoma. 2018;59:1574-1585.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: